Investigator initiated: Conventional prophylactic regimen of oral dexamethasone versus short-course intravenous dexamethasone in preventing paclitaxel-related hypersensitivity reactions in breast and gynecologic-oncology patients: A prospective, randomized, open-label study,
Role: Investigator,
LLU Dept. of Gynecology & Obstetrics,
(02/2024 - 01/2025)
Status: Completed
Investigator Initiated: A Retrospective chart review of patients treated with immune checkpoint inhibitors (ICI) to evaluate severe and fatal adverse events in the emergency department,
Role: Investigator,
LLU Dept. of Pharmacy Practice,
(07/2021 - 10/2024)
Status: Completed
Prevention of Taxol hypersensitivity reactions: Oral dexamethasone given night before and morning of Taxol infusion versus short-course intravenous dexamethasone infusion given 30 minutes prior to Taxol infusion (retrospective review),
Role: Investigator,
LLU Dept. of Pharmacy Practice,
(09/2016 - 09/2017)
Status: Completed
Medication reconciliation in an ambulatory cancer center --impact of the oncology pharmacist,
Role: Investigator,
LLU Dept. of Pharmacy Practice,
(07/2016 - 07/2017)
Status: Completed
Safety and efficacy of pegfilgrastim when given less than 14-days before next chemotherapy cycle: a retrospective review of 14 days regimens containing 5-fluorouracil continuous infusions,
Role: Investigator,
LLU Dept. of Pharmacy Practice,
(07/2016 - 07/2017)
Status: Completed